Live Breaking News & Updates on Maria Sklodowska Curie National Research Institute

Stay updated with breaking news from Maria sklodowska curie national research institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Press Release Media Contacts: IB Communications Tel +44 (0)20 89434685 immutep@ibcomms.agency Immutep announces investigator-initiated Phase II trial

Immutep announces investigator-initiated Phase II trial evaluating LAG-3 candidate eftilagimod alpha (efti) in soft tissue sarcoma Expansion of the efti clinical development pipeline with a new Phase II settingEfti Phase II trial awarded EUR 1.5M (AUD 2.2M) in funding as part of the Polish Medical Research Agen. ....

New South Wales , Katarzyna Kozak , Frederic Triebel , Pawel Sobczuk , Marc Voigt , Maria Sklodowska Curie National Research Institute Of Oncology , Research Agency , Curie National Research Institute Of Oncology , Department Of Soft Tissue Bone Sarcoma , Maria Sklodowska Curie National Research Institute , Institute For Drug , Polish Medical Research Agency , Immutep Limited , Material Transfer Agreement , Curie National Research Institute , Polish State Institute , Drug Control , Principal Investigators , Bone Sarcoma , Sklodowska Curie National Research Institute , Medical Oncology Fellow , Co Principal Investigator ,

NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes

NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes
trend-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from trend-online.com Daily Mail and Mail on Sunday newspapers.

United States , Premio Ischia , Robertw Carlson , Informazione Scientificae Adnkronos , E Los Angeles , Facebook Nccnorg , Papa Giovanni Paolo , View International Adaptations , Ministry Of Health , Health Technology Assessment Agency , Alliance For Innovation , National Health Fund , Maria Sklodowska Curie National Research Institute , National Comprehensive Cancer Network , Cervical Cancer , Sub Saharan Africa , Middle East , North Africa , Poland Edition , Poland Editions , International Adaptations , Practice Guidelines , Informazione Scientifica , Adnkronos Salute ,

Moleculin Reports First Quarter 2021 Financial Results and Provides Programs Update

Moleculin Reports First Quarter 2021 Financial Results and Provides Programs Update
- Multiple ongoing clinical studies expected to drive key clinical and regulatory milestones throughout next 18 months -
- Significantly strengthened financial position extends cash runway through 2023 -
News provided by
Share this article
HOUSTON, May 12, 2021 /PRNewswire/
Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced its financial results for the quarter ended March 31, 2021. The Company also provided an update on its portfolio of oncology drug candidates for the treatment of highly resistant tumors and viruses. ....

United States , Jenene Thomas , Walter Klemp , Moleculin Biotech Inc , Catalyst Clinical Research , Drug Administration , Exchange Commission , Prnewswire Moleculin Biotech Inc , Securities Exchange , Maria Sklodowska Curie National Research Institute , Rare Pediatric Disease Designation , Priority Review Voucher , Fast Track Designation , Generation Anthracycline , Commence Phase , Transcription Modulators , Regulatoryt Cells , Cutaneoust Cell Lymphoma , Diffuse Interstitial Pontine Glioma , Glioblastoma Multiforme , Facilitate Phase , Glycosylation Inhibitor , Emergency Use Authorization , Drugs Controller General , Financial Results , First Quarter ,

Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases

Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases
News provided by
Share this article
Share this article
HOUSTON, Feb. 8, 2021 /PRNewswire/ Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that the Agencja Badań Medycznych (The Medical Research Agency) a Polish state agency responsible for development of scientific research in the field of medical and health sciences, awarded a grant equivalent to $1.5 million USD to the Maria Sklodowska-Curie National Research Institute to fund a Phase 1B/2 clinical trial of Annamycin for the treatment of soft tissue sarcoma (STS) lung metastases. The grant-funded clinical trial will be led by Prof. Piotr Rutkowski, MD, PhD, Head of Department of Soft Tissue/Bone Sarcoma and Melano ....

United States , Agencja Bada , James Salierno Carol Ruth , Walter Klemp , Piotr Rutkowski , Truth Group , Moleculin Biotech Inc , Maria Sklodowska Curie National Research Institute Of Oncology , Exchange Commission , Research Agency , Securities Exchange , Maria Sklodowska Curie National Research Institute , Moleculin Biotech , Medical Research Agency , Bone Sarcoma , Next Generation Anthracycline , Transcription Modulator , Transcription Modulators , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , ஜேம்ஸ் சாலிேறினோ கரோல் ரூத் , வால்டர் க்லேம்ப் , பையட்ர் ருட்கோவ்ஸ்கி , ரூத் குழு ,